The effectiveness of infusion of ascorbic acid and thiamine on the clinical implications of severe sepsis patients admitted to IC
Phase 2
- Conditions
- Sepsis.Sepsis, unspecified
- Registration Number
- IRCT20130812014333N78
- Lead Sponsor
- Vice chancellor for research of Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Dysfunction of organs and SOFA score = 2 in patients whose antibiotic therapy is diagnosed.
SOFA score = 2 in patients whose antibiotic therapy is diagnosed.
Exclusion Criteria
Pregnant women and people under the age of 18; ;
Allergy to ascorbic acid, Chronic hemodialysis, Hemochromatotomy
Sickness to G6PD
Nephropathy oxalate or bilateral erlithiasis
Receive simultaneously other antioxidants
Patients with acquired immunodeficiency disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Organ dysfunction. Timepoint: The first day and fourth day study. Method of measurement: Based on laboratory and clinical criteria.;Length of stay in ICU. Timepoint: 28 days after intervention. Method of measurement: Based on patient records.;Mortality rate. Timepoint: 28 days after intervention. Method of measurement: Based on patient records.
- Secondary Outcome Measures
Name Time Method